Oramed to Present at the Upcoming Canaccord Genuity Annual Growth Conference
07/11/2022 - 07:55 AM
NEW YORK , July 11, 2022 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will present an in-person company overview and share the Company's latest updates at the Canaccord Genuity Annual Growth Conference, to be held in Boston, Massachusetts from August 8-11, 2022 .
Presentation Details:
Canaccord Genuity Annual Growth Conference
Date: Wednesday, August 10, 2022
Time: 4:30 p.m. E.T.
Location: InterContinental Boston Hotel, 510 Atlantic Avenue, Boston, Massachusetts
The presentation will be webcasted. The link to view the presentation will be uploaded to the Oramed website (www.oramed.com ) 48 hours before the event and will be available for 90 days following the presentation.
About Oramed Pharmaceuticals
Oramed Pharmaceuticals (Nasdaq/TASE: ORMP) is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, with offices in the United States and Israel, Oramed has developed a novel Protein Oral Delivery (POD™) technology. Oramed is seeking to transform the treatment of diabetes through its proprietary lead candidate, ORMD-0801 , which is being evaluated in two pivotal Phase 3 studies and has the potential to be the first commercial oral insulin capsule for the treatment of diabetes. In addition, Oramed is developing an oral GLP-1 (Glucagon-like peptide-1) analog capsule.
For more information, please visit www.oramed.com
Company Contact Zach Herschfus +1-844-9-ORAMED zach@oramed.com
Logo - https://mma.prnewswire.com/media/1724339/Oramed_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/oramed-to-present-at-the-upcoming-canaccord-genuity-annual-growth-conference-301583656.html
SOURCE Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals, Inc
ORMP Rankings
#5216 Ranked by Stock Gains
ORMP Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Other, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
New York
About ORMP
oramed pharmaceuticals (nasdaqcm:ormp) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 trials under the usfda, the company is seeking to revolutionize the treatment of diabetes. read more: http://www.oramed.com/investors/corporate-presentation watch: https://www.youtube.com/watch?v=5qchxtdv9eg